GILEAD SCIENCES, INC. (GILD) revenue & profit

GILEAD SCIENCES, INC. (GILD): revenue $29.4B, net income $8.5B in 2025; latest quarter +10.2% year over year. From SEC filings.

$29.4BRevenue 2025

TickerGILD (Nasdaq)

IndustryHealthcare · Biological Products, (No Diagnostic Substances)

Revenue 2025$29.4B

Net income 2025$8.5B

Net margin28.9%

Annual revenue growth+2.4%

Latest quarter (2026 Q2) · Revenue$7.8B

vs. same quarter last year+10.2%

Latest quarter · Net income-$10.5B

Annual revenue & net income

Year	Revenue	Net income
2022	$27.3B	$4.6B
2023	$27.1B	$5.7B
2024	$28.8B	$480M
2025	$29.4B	$8.5B

ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.

↗ Official filings on SEC EDGAR

📷 Coolcaesar · CC BY 4.0 · Wikimedia Commons

About this data

Figures come from the financial statements U.S.-listed companies file with the Securities and Exchange Commission (SEC EDGAR, XBRL data). We use reported annual and quarterly revenue and net income and compare them with the same period a year earlier to calculate growth.

Companies use different fiscal years and sometimes restate past results, and one-off items can make net income jump. This page is for information only and is not investment advice.